Christopher got his start in research as an undergraduate at Harvard, joining the Wagers lab in the Fall of 2018, and wrote a senior’s honor thesis as an undergraduate researcher under the guidance of Dr. Amy Wagers and former lab member Bryan Peacker. In 2020, he graduated, obtaining his degree in Human Developmental and Regenerative Biology. Since then, Christopher has worked as a full-time research assistant in the Wagers Lab, where he has been working to develop therapeutic avenues for treating genetic muscular disorders, such as Duchenne muscular dystrophy, through gene therapy and gene editing modalities.